Cell and Tissue Culture Supplies Market Overview
The global cell and tissue culture supplies market is expected to witness considerable growth during the forecast period on account of advanced applications of cell and tissue culture equipment and consumables in the life science research activities. Moreover, the requisition of optimal environment to conduct cell and tissue related research activities requires customized supplies which increases their demand in the life science industry.
Based on consumable, the cell and tissue culture supplies market is categorized into media, reagent, sera, cryoprotective agents and contamination detection kits. The media category dominated the market during the historical period, mainly due to the increasing demand of customized media for research purposes. The media category is further classified into chemically defined media, classical media, protein-free media, lysogeny broth, serum-free media and specialty media. The reagent category is sub-categorized into protease inhibitors, albumin, thrombin, cytokines and amino acids.
On the basis of type, the cell and tissue culture supplies industry is segregated into culture systems and bioreactors, petri dishes, culture cylinders, roller bottle culture apparatus, syringe filters, spreaders, scrapers and lifters, serological pipettes, and tissue grinders. Multiple well plates, culture bags, tissue culture flasks, culture dishes and roller bottles are some types of culture systems available in the market.
The cell and tissue culture supplies market is categorized into incubators, biosafety cabinets, pipetting instruments and cryostorage equipment, on the basis of instruments.
Globally, North America was the largest revenue generator in the cell and tissue culture supplies industry in 2017, due to advancements in cell culture tools, rise in the demand for animal component-free media and automated cell culture systems. Europe holds the second-largest position in this market, owing to the high demand of cell culture supplies by biotechnology and pharmaceutical companies and research scholars and scientists in the region.
Moreover, it is expected that the cell and tissue culture supplies market in Asia-Pacific will experience the fastest growth during the forecast period. Improving research infrastructure in the region, primarily in India and China, and the increasing outsourcing of biopharmaceuticals are major factors that contributes to the promising market growth in the region in the coming years. In addition, innovative and advanced applications of cell culture and tissue culture techniques in agriculture is also supporting the growth of market in the developing economies of the region. This is mainly due to increasing government support in the form of funds and grants for research projects, which requires latest cell and tissue techniques-based equipment and consumables.
Cell and Tissue Culture Supplies Market Dynamics
Some of the major factors contributing to the growth of cell and tissue culture supplies industry are growing applications of cell and tissue culture equipment and consumables across numerous fields, such as vaccines and antibodies production, disease treatment, and drug discovery; increasing prevalence of chronic diseases; rising awareness about cell culture techniques; and advent of 3D cell culture models in the life sciences industry.
Furthermore, the growing popularity of contract research and manufacturing outsourcing; increasing demand of serum-free, specialty, and customized media solutions; and surge in the demand for biopharmaceuticals and regenerative medicine are expected to drive the market growth.
Moreover, increase in investments to support research activities by utilizing cell and tissue equipment and consumables is also promoting the market growth. For instance, in April 2018, STEMCELL Technologies Inc. (STEMCELL), a provider of cell culture supplies and services, announced a $45 million joint funding agreement between the Governments of Canada and British Columbia, to build an advanced state-of-the-art manufacturing facility. The objective of this funding agreement was to accelerate STEMCELL’s business by providing cutting-edge reagents and tools to support life science researchers working in the cell therapy and regenerative medicine fields.
However, stringent regulatory requirements, high cost and affordability issue, and complexity in cell culture techniques are some of the factors restraining the growth of the cell and tissue culture supplies industry.
Cell and Tissue Culture Supplies Market Competitive Landscape
The market players are strengthening their position in the cell and tissue culture supplies market by adopting the acquisition strategy. For instance, in September 2018, Thermo Fisher Scientific Inc. (Thermo Fisher), signed a definitive agreement with Becton, Dickinson and Company (BD), a medical technology company, to acquire BD's Advanced Bioprocessing business. The acquisition is subjected to customary closing conditions and is expected to close in early 2019. After the completion of this acquisition, the acquired business would be integrated into Thermo Fisher's Life Sciences Solutions segment. Thermo Fisher Life Sciences, through its various service programs, will enhance cell culture media formulations to improve yield and reduce variability in biopharmaceutical applications.
Some of the other key players in the cell and tissue culture supplies industry are Merck KGaA; VWR International LLC; Lonza Group; Corning Inc.; DWK Life Sciences Inc.; Affymetrix Inc.; Becton, Dickinson and Company; GE Healthcare; and Eppendorf AG.
The market study provides comprehensive understanding of the market with the help of informed market outlook, opportunities, challenges, trends, size and growth, competitive analysis, major competitors and Porter’s analysis. Along with this, it highlights the competitive scenario of the market, major competitors, market share, benchmarking, investments and merger and acquisitions.